Dr. Constancio Medrano López

President of the Spanish Society of Pediatric Cardiology and Congenital Heart Disease.

• Associate Professor of Pediatrics. Faculty of Medicine. Complutense University of Madrid
• Member of the Research Commission and Head of Training at the Gregorio Marañon Health Research Institute in Madrid. From 2008 to the present.
• Principal Investigator in R+D+i projects financed in public competitive calls:
  
  Stem Cell Therapy: Feasibility and safety clinical trial of intramyocardial injection of autologous bone marrow-derived stem cells in children with hypoplastic left ventricular syndrome. The TABHY study. Carlos III Institute of Health
  
  Drugs in Pulmonary Hypertension: Sildenafil in postoperative cardiac surgery in children. IVORY study. Carlos III Health Institute.
  
  Familial Cardiopathies and Genetics: MYESTELA Study: Multicentric Study of Myocardiopathies in Childhood. Genetic study and with new echocardiographic techniques (2D Speckle tracking) and familial impact. Carlos III Health Institute.

• Coordinator-Principal Investigator in privately funded R+D+I projects:
  
  National Coordinator of the CIVIC Studies (Epidemiological studies of acute respiratory infections due to respiratory syncytial virus in children with heart disease). Spanish Society of Pediatric Cardiology and Congenital Heart Disease (SECPCC) - Abbvie. From 2004 to the present.
  
  Regional Coordinator (Europe II) and Member of the Steering Committee of the CLARINET Study: International, multicenter clinical trial on the use of clopidogrel in young children to reduce the risk of thrombosis in ducts and systemic pulmonary fistulas in cyanogenic congenital heart disease. Start in 2006

Visiting Medical Specialist in the Pediatric Cardiology Service (Hemodynamics and Fetal Cardiology) at the Hospital Sainte Justine de Montréal (Québec, Canada). 1999.

Spanish